NCT04890665

Brief Summary

The objective of this study is to carry out a randomized clinical trial with healthcare workers in Mexico through a web platform. The intervention aims to reduce anxiety, depressive symptoms, burnout, stress, compassion fatigue, and increase the quality of life and sleep and self-care, as well as improve skills in providing bad news to patients and their families. A self-applied intervention will be compared with an intervention delivered by therapists providing the same intervention implemented through Zoom, Skype, or Microsoft Teams, to ensure sanitary protection measures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 17, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 18, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

July 16, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2022

Completed
Last Updated

October 5, 2021

Status Verified

September 1, 2021

Enrollment Period

11 months

First QC Date

May 17, 2021

Last Update Submit

September 27, 2021

Conditions

Outcome Measures

Primary Outcomes (6)

  • The Center for Epidemiologic Studies Depression Scale-Revised (CESD-R)

    The CESD-R is an updated version of the CES-D. The CESD-R consists of 20. This scale assesses the number of depression symptoms within 2 weeks. The scale consists 20 items and contains 4-point score responses (0 to 3) as the following; rarely or none of the time (less than 1 day); some of a little of the time (1-2 days); occasionally or moderate amount of time (3-4 days) and most or all of the time (5-7 days). The total possible range of scores is from 0 to 60 where \^16 is the cut-off point for this scale, and higher scores indicate more symptoms of depression. It is expected a statistically significant decrease (P \< 0.05) in depression symptoms.

    Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 nuclear modules.

  • Decrease in the symptoms of General Anxiety Disorder (GAD-7)

    On the Generalized Anxiety Disorder 7-item (GAD-7) scale subjects are asked how often, during the last 2 weeks, they have been bothered by each of the 7 core symptoms of generalized anxiety disorder. Response options are "not at all," "several days," "more than half the days," and "nearly every day," scored as 0, 1, 2, and 3, respectively. Therefore, GAD-7 scores range from 0 to 21, with scores of ≥5, ≥10, and ≥15 represent mild, moderate, and severe anxiety symptom levels, respectively. Is expected a statistically significant decrease (P \< 0.05) in the General Anxiety symptoms.

    Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 nuclear modules.

  • Decrease in the score of The Pittsburgh Sleep Quality Index (PSQI).

    This instrument assesses the quality patterns of sleep. It differentiates the "poor" and "good" sleep by measuring seven areas, where the range score of answers are from 0 to 3, the global sum of this scale can be a value between 0 to 60, and the cutoff point is "5" that indicates a "poor" sleep quality. It is expected a statistically significant decrease (P \< 0.05) in the Sleep Quality measure.

    Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 nuclear modules.

  • Decrease in the scores of the Post-Traumatic Stress Disorder Symptom Scale (PSS)

    The Post-Traumatic Stress Disorder Symptom Scale is a 17-item structured interview. The severity over the last 2 weeks of each item on the PSS is rated by the interviewer using a 4-point scale: 0 = not at all, 1 = a little bit, 2 = somewhat, and 3 = very much. The maximum possible score is 51 (severely affected) and the minimum possible score is 0 (total absence of the symptoms). The total severity score is calculated as the sum of the severity ratings for the 17 items. The diagnosis of the Post-Traumatic Stress Disorder Symptom Scale is made when at least 1 re-experiencing, 3 avoidance, and 2 arousal symptoms are endorsed on the scale by individuals who were traumatized at least one month prior to the assessment. It is expected a statistically significant decrease (P \< 0.05) in the symptoms of Post-Traumatic Stress Disorder in the patients suffering from this disorder.

    Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 nuclear modules.

  • Increase in the score of the Professional Quality of Life Measure (ProQOL)

    The professional quality of life will be evaluated with the ProQOL scale (Professional Quality of Life Measure). This scale measures the sections of Satisfaction by empathy, compassion fatigue, and Burnout. The scale is composed of 30 Likert-type questions with five possible answers, being: Never = 1, Rarely = 2, Sometimes = 3, Often = 4 and Often = 5. A score of 17 could indicate affect action in the measured dimensions. It is expected a statistically significant decrease (P \< 0.05) in the perception of Professional Quality of Life of the patients.

    Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 nuclear modules.

  • Increase in the score of the Appraisal of Self-care Agency (ASA)

    This scale is made up of 24 Likert-type reagents with four types of response, which have a score of one to four points, which when performing the final sum may result in the range of 24-96. The higher the resulting score, the greater the person's self-care capabilities. Maximum ability of self-care is reflected with a score of 96 and a minimum with 24, where high scores of self-care are with scores equal or higher to 76, for a medium ability with equal or higher to 70 but equal or lower than 75 and a low ability any score of 69 or lower. It is expected a statistically significant increase (P \< 0.05) in the in the score of the Appraisal of Self-care Agency.

    Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 nuclear modules.

Secondary Outcomes (2)

  • Decrease in the Plutchik Suicide Risk Scale (BSI)

    Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 nuclear modules.

  • Increase in the Scale for measuring resilience with Mexicans (RESI-M)

    Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 nuclear modules.

Study Arms (2)

Experimental: Self-applied psychological intervention for healthcare workers

EXPERIMENTAL

Participants in this group will receive 9 sessions of a multi-component psychological intervention focused on the reduction of symptoms of anxiety, depression, stress, burnout, fatigue compassion, and post-traumatic stress, and the increase of the quality of sleep and perception of the quality of life. The participants will have the option to do 3 extra modules that are complimentary for the intervention.

Behavioral: Online psychological intervention for healthcare workers

Control: Self-applied psychological intervention for healthcare workers

ACTIVE COMPARATOR

The participants in this group will receive exactly the same intervention but delivered through a therapist in a weekly session through an online video call. The participants will be informed also about the 3 extra modules and briefly what it is the contents of these modules so they can accept or not receive these extra contents.

Behavioral: Online psychological intervention for healthcare workers

Interventions

The intervention is based on Cognitive Behavioral Therapy, Mindfulness, Behavioral Activation Therapy, Acceptance and Commitment Therapy and Positive Psychology, aimed at the Psychoeducation regarding the manifestations of anxiety, depression, burnout, fatigue compassion, posttraumatic stress disorder, and affectations in sleep quality and perception of life quality in healthcare workers. And 3 complementary modules that according to the scientific literature could affect the mental health of healthcare workers related to how to deliver bad health news, Psychological first aid and how beliefs could influence physical and emotional self-care in the face of the COVID-19 pandemic.

Control: Self-applied psychological intervention for healthcare workersExperimental: Self-applied psychological intervention for healthcare workers

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To have access to a communication device with access to the internet (computer, tablet, and mobile)
  • To have a valid email address.
  • To have basic digital skills in the use of an operational system and internet browsing.
  • To understand Spanish since all the contents are in this language.
  • Symptoms of anxiety, depression, burnout, and fatigue compassion

You may not qualify if:

  • To have a diagnosis of psychotic disorder
  • To be receiving psychological and/or pharmacological treatment during the study
  • Moderate to a high score on the suicide scale
  • Recent attempt of suicide (3 months)
  • To refuse to accept to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Universidad Autónoma de Ciudad Juárez

Juárez, Chihuahua, 32315, Mexico

RECRUITING

Universidad de Guadalajara

Guadalajara, Jalisco, 44160, Mexico

NOT YET RECRUITING

Universidad Nacional Autónoma de México

México, 54090, Mexico

NOT YET RECRUITING

Related Publications (22)

  • Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, Wu J, Du H, Chen T, Li R, Tan H, Kang L, Yao L, Huang M, Wang H, Wang G, Liu Z, Hu S. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw Open. 2020 Mar 2;3(3):e203976. doi: 10.1001/jamanetworkopen.2020.3976.

    PMID: 32202646BACKGROUND
  • Shechter A, Diaz F, Moise N, Anstey DE, Ye S, Agarwal S, Birk JL, Brodie D, Cannone DE, Chang B, Claassen J, Cornelius T, Derby L, Dong M, Givens RC, Hochman B, Homma S, Kronish IM, Lee SAJ, Manzano W, Mayer LES, McMurry CL, Moitra V, Pham P, Rabbani L, Rivera RR, Schwartz A, Schwartz JE, Shapiro PA, Shaw K, Sullivan AM, Vose C, Wasson L, Edmondson D, Abdalla M. Psychological distress, coping behaviors, and preferences for support among New York healthcare workers during the COVID-19 pandemic. Gen Hosp Psychiatry. 2020 Sep-Oct;66:1-8. doi: 10.1016/j.genhosppsych.2020.06.007. Epub 2020 Jun 16.

    PMID: 32590254BACKGROUND
  • Paul V, Patel S, Royse M, Odish M, Malhotra A, Koenig S. Proning in Non-Intubated (PINI) in Times of COVID-19: Case Series and a Review. J Intensive Care Med. 2020 Aug;35(8):818-824. doi: 10.1177/0885066620934801.

    PMID: 32633215BACKGROUND
  • Allan SM, Bealey R, Birch J, Cushing T, Parke S, Sergi G, Bloomfield M, Meiser-Stedman R. The prevalence of common and stress-related mental health disorders in healthcare workers based in pandemic-affected hospitals: a rapid systematic review and meta-analysis. Eur J Psychotraumatol. 2020 Oct 16;11(1):1810903. doi: 10.1080/20008198.2020.1810903.

    PMID: 33244359BACKGROUND
  • Pappa S, Ntella V, Giannakas T, Giannakoulis VG, Papoutsi E, Katsaounou P. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis. Brain Behav Immun. 2020 Aug;88:901-907. doi: 10.1016/j.bbi.2020.05.026. Epub 2020 May 8.

    PMID: 32437915BACKGROUND
  • Luo M, Guo L, Yu M, Jiang W, Wang H. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public - A systematic review and meta-analysis. Psychiatry Res. 2020 Sep;291:113190. doi: 10.1016/j.psychres.2020.113190. Epub 2020 Jun 7.

    PMID: 32563745BACKGROUND
  • Smith GD, Ng F, Ho Cheung Li W. COVID-19: Emerging compassion, courage and resilience in the face of misinformation and adversity. J Clin Nurs. 2020 May;29(9-10):1425-1428. doi: 10.1111/jocn.15231. Epub 2020 Mar 10. No abstract available.

    PMID: 32155302BACKGROUND
  • Hossain F, Clatty A. Self-care strategies in response to nurses' moral injury during COVID-19 pandemic. Nurs Ethics. 2021 Feb;28(1):23-32. doi: 10.1177/0969733020961825. Epub 2020 Oct 30.

    PMID: 33124492BACKGROUND
  • Williamson V, Stevelink SAM, Greenberg N. Occupational moral injury and mental health: systematic review and meta-analysis. Br J Psychiatry. 2018 Jun;212(6):339-346. doi: 10.1192/bjp.2018.55.

    PMID: 29786495BACKGROUND
  • Drissi N, Ouhbi S, Marques G, de la Torre Diez I, Ghogho M, Janati Idrissi MA. A Systematic Literature Review on e-Mental Health Solutions to Assist Health Care Workers During COVID-19. Telemed J E Health. 2021 Jun;27(6):594-602. doi: 10.1089/tmj.2020.0287. Epub 2020 Sep 22.

    PMID: 32970532BACKGROUND
  • Yang L, Yin J, Wang D, Rahman A, Li X. Urgent need to develop evidence-based self-help interventions for mental health of healthcare workers in COVID-19 pandemic. Psychol Med. 2021 Jul;51(10):1775-1776. doi: 10.1017/S0033291720001385. Epub 2020 Apr 28. No abstract available.

    PMID: 32340642BACKGROUND
  • Koslowsky M, Bleich A, Greenspoon A, Wagner B, Apter A, Solomon Z. Assessing the validity of the Plutchik Suicide Risk Scale. J Psychiatr Res. 1991;25(4):155-8. doi: 10.1016/0022-3956(91)90019-7.

    PMID: 1779413BACKGROUND
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.

  • Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.

  • Novy DM, Stanley MA, Averill P, Daza P. Psychometric comparability of English- and Spanish-language measures of anxiety and related affective symptoms. Psychol Assess. 2001 Sep;13(3):347-55. doi: 10.1037//1040-3590.13.3.347.

  • Foa EB, Cashman L, Jaycox L, Perry K. The validation of a self-report measure of posttraumatic stress disorder: the Posttraumatic Diagnostic Scale. Psychological assessment. 1997 Dec;9(4):445.

    RESULT
  • González-Forteza C, Torres CS, Tapia AJ, Fernández IH, González-González A, Garcia FJ, Medina-Mora ME, Mejía HFV. Confiabilidad y validez de la escala de depresión CES-D en un censo de estudiantes de nivel medio superior y superior, en la Ciudad de México [Reliability and validity of the depression scale CES-D in high school and college students from Mexico City: Results from a census]. Salud Mental. 2011; 34(1): 53-59.

    RESULT
  • Garcia-Campayo J, Zamorano E, Ruiz MA, Pardo A, Perez-Paramo M, Lopez-Gomez V, Freire O, Rejas J. Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual Life Outcomes. 2010 Jan 20;8:8. doi: 10.1186/1477-7525-8-8.

  • Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76-82. doi: 10.1002/da.10113.

  • Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict. 2022;20(3):1537-1545. doi: 10.1007/s11469-020-00270-8. Epub 2020 Mar 27.

  • Healy DJ, Barry K, Blow F, Welsh D, Milner KK. Routine use of the Beck Scale for Suicide Ideation in a psychiatric emergency department. Gen Hosp Psychiatry. 2006 Jul-Aug;28(4):323-9. doi: 10.1016/j.genhosppsych.2006.04.003.

  • Dominguez-Rodriguez A, Martinez-Arriaga RJ, Herdoiza-Arroyo PE, Bautista-Valerio E, de la Rosa-Gomez A, Castellanos Vargas RO, Lacomba-Trejo L, Mateu-Molla J, Lupercio Ramirez MJ, Figueroa Gonzalez JA, Ramirez Martinez FR. E-Health Psychological Intervention for COVID-19 Healthcare Workers: Protocol for its Implementation and Evaluation. Int J Environ Res Public Health. 2022 Oct 5;19(19):12749. doi: 10.3390/ijerph191912749.

MeSH Terms

Conditions

Anxiety DisordersDepressionParasomniasBurnout, ProfessionalCompassion Fatigue

Interventions

Health Personnel

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehaviorSleep Wake DisordersNervous System DiseasesOccupational StressOccupational DiseasesBurnout, PsychologicalStress, PsychologicalMental FatigueFatigueSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Health Care Facilities Workforce and Services

Study Officials

  • Anabel de la Rosa Gómez, PhD

    Universidad Nacional Autonoma de Mexico

    STUDY CHAIR
  • Paulina Erika Herdoiza Arroyo, PhD

    Universidad Internacional del Ecuador

    STUDY CHAIR
  • Rosa Olimpia Castellanos Vargas, MD

    Universidad Autonoma de Ciudad Juarez

    STUDY CHAIR
  • Joaquín Mateu Molla, PhD

    Valencian International University

    STUDY CHAIR
  • Luis Farfallini, PhD

    University of Buenos Aires

    STUDY CHAIR
  • Eduardo Bautista Valerio, BD

    Universidad Nacional Autonoma de Mexico

    STUDY CHAIR

Central Study Contacts

Alejandro Dominguez Rodriguez, PhD

CONTACT

Reyna Jazmin Martinez Arriaga, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patients are not aware that there is an experimental group and a control group, the participants are not related and do not know each other. The conditions of the study are only known by the researcher, the therapists, and the Research Ethics Committee of the Universidad Autónoma de Ciudad Juárez.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study has two arms, one is the experimental group that receives the treatment solely through the online platform, and the other is the comparison group that will receive treatment delivered through a therapist through video calls. The patients in both groups will be evaluated pre and post/treatment. The participants are assigned randomly to the intervention or comparison group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 17, 2021

First Posted

May 18, 2021

Study Start

July 16, 2021

Primary Completion

June 20, 2022

Study Completion

June 20, 2022

Last Updated

October 5, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will share

The information will be available in a private server or in a server of the journal(s) that we will publish the articles that will be the result of this study. The protocol of the study is currently in progress to be published, in this article will be included such study protocol, the informed consent is already shared in the register of clinical trials.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
This data will be available approximately in June 2022 and it will be permanently available. It will be shared in the databases of the journal where the article(s) will be published.
Access Criteria
Through the servers of the journal(s) where we will publish the articles.

Locations